Literature DB >> 20963625

Myocardial NOS activity and connexin-43 expression in untreated and omega-3 fatty acids-treated spontaneously hypertensive and hereditary hypertriglyceridemic rats.

Jana Radosinska1, Barbara Bacova, Iveta Bernatova, Jana Navarova, Anna Zhukovska, Angela Shysh, Ludmila Okruhlicova, Narcis Tribulova.   

Abstract

The purpose of this study is to investigate myocardial nitric oxide synthase (NOS) activity and connexin-43 (Cx43) expression in young and old spontaneously hypertensive rats (SHR), adult hereditary hypertriglyceridemic (HTG) rats, and age-matched healthy rats without and with omega-3 PUFA supplementation for 2 months. Results showed that comparing to healthy rats the myocardial NOS activity was significantly increased in young SHR (8.2 ± 1.16 vs. 1.37 ± 0.67 pmol/min/mg) as well as old SHR (3.21 ± 0.75 vs. 2.22 ± 0.56 pmol/min/mg) and to much lesser extent in HTG rats, i.e., 1.87 ± 0.42 vs. 1.34 ± 0.1 pmol/min/mg. In parallel, there was a significant decline of total and phosphorylated forms of Cx43 in both groups of SHR while not in HTG rat hearts in which phosphorylated form of Cx43 was increased. Elevated NOS activity was suppressed (P < 0.05) in young and old SHR supplemented with omega-3 PUFA and it was associated with up-regulation of Cx43. In contrast to SHR, elevation of NOS activity in HTG rat hearts was not affected by treatment with omega-3 PUFA. However, increase of phosphorylated form of Cx43 was suppressed. In conclusion, there is an inverse relationship between myocardial NOS activity and Cx43 expression in SHR while not HTG rat hearts and omega-3 PUFA modulate both NOS activity and Cx43 expression. Whether over-expression of inducible NOS might account for down-regulation of myocardial Cx43 and whether its up-regulation is associated with an increase of endothelial NOS should be explored in further study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20963625     DOI: 10.1007/s11010-010-0625-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  45 in total

Review 1.  Gap junction channels in the cardiovascular system: pharmacological and physiological modulation.

Authors:  S Dhein
Journal:  Trends Pharmacol Sci       Date:  1998-06       Impact factor: 14.819

2.  Myocardial Ca2+ handling and cell-to-cell coupling, key factors in prevention of sudden cardiac death.

Authors:  Narcis Tribulova; Shingo Seki; Jana Radosinska; Peter Kaplan; Eva Babusikova; Vladimir Knezl; Seibu Mochizuki
Journal:  Can J Physiol Pharmacol       Date:  2009-12       Impact factor: 2.273

3.  Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats.

Authors:  N D Vaziri; Z Ni; F Oveisi; D L Trnavsky-Hobbs
Journal:  Hypertension       Date:  2000-12       Impact factor: 10.190

4.  Sex differences in connexin-43 expression in left ventricles of aging rats.

Authors:  N Tribulová; E Dupont; T Soukup; L Okruhlicová; N J Severs
Journal:  Physiol Res       Date:  2005       Impact factor: 1.881

5.  The expression of heme oxygenase-1 and inducible nitric oxide synthase in aorta during the development of hypertension in spontaneously hypertensive rats.

Authors:  Pao-Yun Cheng; Jin-Jer Chen; Mao-Hsiung Yen
Journal:  Am J Hypertens       Date:  2004-12       Impact factor: 2.689

6.  Docosahexaenoic acid (22:6n-3) enrichment of membrane phospholipids increases gap junction coupling capacity in cultured astrocytes.

Authors:  Gaelle Champeil-Potokar; Catherine Chaumontet; Philippe Guesnet; Monique Lavialle; Isabelle Denis
Journal:  Eur J Neurosci       Date:  2006-12       Impact factor: 3.386

7.  Nitric oxide specifically reduces the permeability of Cx37-containing gap junctions to small molecules.

Authors:  Petra Kameritsch; Natascha Khandoga; Wolfram Nagel; Christina Hundhausen; Darcy Lidington; Ulrich Pohl
Journal:  J Cell Physiol       Date:  2005-04       Impact factor: 6.384

8.  Enhancement of caffeine-induced locomotor hyperactivity produced by the combination with L-arginine or taurine in mice: Possible involvement of nitric oxide.

Authors:  M Kimura; I Ushijima; M Hiraki; M Kimura; Nobufumi Ono
Journal:  Methods Find Exp Clin Pharmacol       Date:  2009-11

Review 9.  Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects.

Authors:  Iveta Bernatova; M Victoria Conde; Jana Kopincova; M Carmen González; Angelika Puzserova; Silvia M Arribas
Journal:  J Hypertens Suppl       Date:  2009-08

Review 10.  eNOS, metabolic syndrome and cardiovascular disease.

Authors:  Paul L Huang
Journal:  Trends Endocrinol Metab       Date:  2009-07-31       Impact factor: 12.015

View more
  13 in total

1.  Antioxidant SMe1EC2 may attenuate the disbalance of sodium homeostasis in the organism induced by higher intake of cholesterol.

Authors:  Lucia Mézešová; Veronika Jendruchová-Javorková; Jana Vlkovičová; Zuzana Kyselova; Jana Navarová; Stefan Bezek; Norbert Vrbjar
Journal:  Mol Cell Biochem       Date:  2012-03-22       Impact factor: 3.396

Review 2.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Authors:  Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

3.  Omega-3 polyunsaturated fatty acids promote liver regeneration after 90% hepatectomy in rats.

Authors:  Yu-Dong Qiu; Sheng Wang; Yue Yang; Xiao-Peng Yan
Journal:  World J Gastroenterol       Date:  2012-07-07       Impact factor: 5.742

4.  Protective effects of fish oil, allopurinol, and verapamil on hepatic ischemia-reperfusion injury in rats.

Authors:  Basim Anwar Shehata Messiha; Amira M Abo-Youssef
Journal:  J Nat Sci Biol Med       Date:  2015 Jul-Dec

5.  Omega-3 polyunsaturated fatty acid-enriched diet differentially protects two subpopulations of myocardial mitochondria against Ca(2+)-induced injury.

Authors:  Olga Panasiuk; Angela Shysh; Alexander Bondarenko; Oleksiy Moibenko
Journal:  Exp Clin Cardiol       Date:  2013

6.  Heart-protective effect of n-3 PUFA demonstrated in a rat model of diabetic cardiomyopathy.

Authors:  Zhukovska Anna; Shysh Angela; Bacova Barbara; Radosinska Jana; Benova Tamara; Viczenczova Csilla; Dosenko Victor; Moybenko Oleksiy; Tribulova Narcisa
Journal:  Mol Cell Biochem       Date:  2013-12-31       Impact factor: 3.396

7.  Intervention of Ayurvedic drug Tinospora cordifolia attenuates the metabolic alterations in hypertriglyceridemia: a pilot clinical trial.

Authors:  Amey Shirolkar; Aarti Yadav; T K Mandal; Rajesh Dabur
Journal:  J Diabetes Metab Disord       Date:  2020-10-16

8.  Regulation of gap junctions by nitric oxide influences the generation of arrhythmias resulting from acute ischemia and reperfusion in vivo.

Authors:  Agnes Végh; Márton Gönczi; Gottfried Miskolczi; Mária Kovács
Journal:  Front Pharmacol       Date:  2013-06-14       Impact factor: 5.810

9.  Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculature.

Authors:  Debra A Mayes; Tilat A Rizvi; Haley Titus-Mitchell; Rachel Oberst; Georgianne M Ciraolo; Charles V Vorhees; Andrew P Robinson; Stephen D Miller; Jose A Cancelas; Anat O Stemmer-Rachamimov; Nancy Ratner
Journal:  Cell Rep       Date:  2013-09-12       Impact factor: 9.423

10.  Intake of n-3 Polyunsaturated Fatty Acids Increases Omega-3 Index in Aged Male and Female Spontaneously Hypertensive Rats.

Authors:  Barbara Bačová; Peter Seč; Milan Certik; Narcis Tribulova
Journal:  ISRN Nutr       Date:  2013-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.